Enovis (ENOV) Change in Account Payables (2012 - 2026)
Enovis' (ENOV) quarterly Change in Account Payables came in at $26.9 million in Q2 2026, up 541.85% year-on-year from $4.2 million in Q2 2025, and up 334.17% on a QoQ basis from -$11.5 million in Q4 2025.
Enovis (ENOV) Change in Account Payables (2012 - 2026) Analysis & Trends
Enovis (ENOV) has 15 years of Change in Account Payables data on file, last reported at $26.9 million in Q2 2026.
- On a quarterly basis, Change in Account Payables rose 541.85% year-over-year to $26.9 million in Q2 2026; TTM through Apr 2026 was $21.6 million, a 27.95% decrease from a year earlier, with the FY2025 full-year figure at -$1.1 million, down 108.13% from the prior year.
- Change in Account Payables for Q2 2026 stood at $26.9 million, up from -$11.5 million in the prior quarter.
- Over the last five years, Change in Account Payables for ENOV reached as high as $26.9 million in Q2 2026 and fell as low as -$46.0 million in Q4 2022.
- Historically, Change in Account Payables has averaged $1.3 million across 5 years, with a median of $4.2 million in 2025.
- Across the five-year window, Change in Account Payables slumped 232.26% in 2022 and jumped 541.85% in 2026, its largest moves.
- Year by year, Change in Account Payables stood at -$46.0 million in 2022, then jumped by 112.48% to $5.7 million in 2023, then jumped by 343.91% to $25.5 million in 2024, then sank by 145.05% to -$11.5 million in 2025, then surged by 334.17% to $26.9 million in 2026.
- Per Business Quant data, the three most recent Change in Account Payables figures were $26.9 million in Q2 2026, -$11.5 million in Q4 2025, and -$12.8 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Enovis | 1.50 Bn | 1.47 Bn | 365.49 Mn | 26.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 26.89 Mn |
| Apr 3, 2026 | 26.89 Mn |
| Dec 31, 2025 | -11.48 Mn |
| Dec 31, 2025 | -11.48 Mn |
| Oct 3, 2025 | -12.82 Mn |
| Oct 3, 2025 | -12.82 Mn |
| Jul 4, 2025 | 18.97 Mn |
| Jul 4, 2025 | 18.97 Mn |
| Apr 4, 2025 | 4.19 Mn |
| Apr 4, 2025 | 4.19 Mn |
| Dec 31, 2024 | 25.49 Mn |
| Dec 31, 2024 | 25.49 Mn |
| Sep 27, 2024 | -4.76 Mn |
| Sep 27, 2024 | -4.76 Mn |
| Jun 28, 2024 | 5.01 Mn |
| Jun 28, 2024 | 5.01 Mn |
| Mar 29, 2024 | -11.75 Mn |
| Mar 29, 2024 | -11.75 Mn |
| Dec 31, 2023 | 5.74 Mn |
| Dec 31, 2023 | 5.74 Mn |